Data from two studies presented at the Conference on Retroviruses and Opportunistic Infections support the use of a novel, ...
HIV criminalization arose in an atmosphere of fearful ignorance, disproportionately harming Black men. But activists are ...
But access to treatment could be in jeopardy if potential budget cuts, announced in January 2026 by the Florida Department of Health, are enacted. These changes, set to go into effect on March 1, ...
Pritelivir, an investigational antiviral drug for herpes simplex virus, demonstrated “superior efficacy” in healing lesions ...
The emergency rule comes just one day before a planned hearing between the DOH and the AIDS Healthcare Foundation.
Indiana senators have given final approval on a bill extending syringe services programs in the state another five years. It now heads to Gov. Mike Braun’s desk. Syringe services programs provide ...
It’s high time to change this and focus on sexual and reproductive health for men. Every single unplanned pregnancy involves ...
People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new ...
The state invoked emergency rule-making power for what advocates say will be another emergency, when HIV-positive patients ...
As GSK’s HIV unit ViiV Healthcare grapples with a new rival in the injectable HIV prevention and treatment field, the company is reinforcing the staying power of its long-acting treatment Cabenuva | ...
Tallahassee health officials have pushed through an emergency rule that would dramatically tighten who qualifies for ...
At the 2026 Conference on Retroviruses and Opportunistic Infections, Gilead and Merck demonstrated that their respective daily oral HIV drugs can match current therapies in keeping the virus at bay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results